Bruce J. Giantonio
Department of Medicine
The University of Pennsylvania School of Medicine
Philadelphia
PA 19103
USA
Name/email consistency: high
- The role of the Eastern Cooperative Oncology Group in establishing standards of cancer care: over 50 years of progress through clinical research. Giantonio, B.J., Forastiere, A.A., Comis, R.L. Semin. Oncol. (2008)
- Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. Giantonio, B.J., Catalano, P.J., Meropol, N.J., O'Dwyer, P.J., Mitchell, E.P., Alberts, S.R., Schwartz, M.A., Benson, A.B. J. Clin. Oncol. (2007)
- A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. Giantonio, B.J., Levy, D.E., O'dwyer, P.J., Meropol, N.J., Catalano, P.J., Benson, A.B. Ann. Oncol. (2006)
- Phase I and pharmacokinetic study of the cytotoxic ether lipid ilmofosine administered by weekly two-hour infusion in patients with advanced solid tumors. Giantonio, B.J., Derry, C., McAleer, C., McPhillips, J.J., O'Dwyer, P.J. Clin. Cancer Res. (2004)
